Figure GPS-33 Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) – Part (i) Cannabis use – lifetime experience, recent use (last 12 months) and current use (last 30 days)

Figure GPS-33 part i


For details of the studies included see Table GPS-1 to Table GPS-6.

The chart shows the overall average of the relevant studies, weighted by sample size.

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national reports (2005), taken from population surveys, reports or scientific articles.

See also Table GPS-0.